Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Download PDF

Association between laboratory markers, clinical and radiological findings in patients with idiopathic intracranial hypertension: case–control study

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery volume 60, Article number: 115 (2024) Cite this article

Abstract

Background

Idiopathic intracranial hypertension (IIH) is a disease of raised intracranial pressure. Contribution of inflammatory mediators has been suggested in IIH pathophysiology. The aim of this study was to estimate certain serum inflammatory markers in IIH patients compared to normal subjects. Also, to examine the correlation between these laboratory parameters and the clinical and radiological characteristics of IIH patients.

Results

Body mass index (BMI) was significantly higher among IIH patients compared to controls. Serum LDH, CRP, NLR and PLR were significantly higher, whereas serum iron was significantly lower in IIH patients compared to healthy controls. IIH patients with stenosis in brain MRV had significantly higher mean serum CRP compared with patients with normal MRV. There was a statistically significant positive correlation between serum CRP and the presence of stenosis in MRV, between serum LDH level and grade of papilledema, and between CRP, TIBC, and NLR with BMI.

Conclusions

There is a significant elevation of inflammatory markers in IIH patients. Moreover, cerebral venous sinus stenosis and BMI were positively associated with higher markers of inflammation as CRP, LDH and NLR indicating the role of inflammation in thrombosis and obesity associated with IIH.

Introduction

Idiopathic intracranial hypertension (IIH) is a disorder which affects mainly the overweight females in the childbearing age characterized by chronic elevation of intracranial pressure which usually manifests by headache in most of patients. It is usually frontal or around the orbit, throbbing in nature and may be accompanied by tinnitus, nausea and transient visual obscurations (TVOs). Papilledema is another important and common sign in IIH which may be complicated by secondary progressive optic atrophy, visual loss, and possible blindness [1].

The pathogenesis of IIH is yet unknown. The choroid plexus's increased cerebrospinal fluid (CSF) production or the arachnoid granulation tissue's restricted CSF drainage, which are both worsened by an elevated venous sinus pressure, are the causes of abnormal cerebrospinal fluid dynamics [2].

In patients with IIH, signs of low-grade inflammation were reported in several studies, particularly in overweight women. Researchers advocated that multiple pro‑inflammatory adipocytes can be used as markers which may help expecting the prognosis in IIH [3].

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been discovered to be useful inflammatory markers for a variety of chronic disorders including some ophthalmological diseases, and can help in expecting their prognosis [4].

There is also a growing evidence that iron deficiency anemia (IDA) is one of important factors in some patients with elevated intracranial pressure (ICP), and confirms the importance of searching for concomitant IDA in IIH patients and treating it. This is reinforced by the diagnostic criteria for IIH suggested by Friedman and Jacobson which identify severe IDA as a condition that can cause intracranial hypertension and resemble IIH [5].

The aim of this study is to estimate certain serum markers (lactic dehydrogenase (LDH), C-reactive protein CRP, serum iron, total iron binding capacity (TIBC), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in patients with IIH compared to healthy subjects. Also, to investigate the correlation between these laboratory parameters and grade of papilledema, grade of perimetry, opening CSF pressure and magnetic resonance venography (MRV) findings.

Methods

This is a case–control study carried on 72 subjects (36 patients diagnosed as IIH and 36 matched healthy controls). The research was conducted at the Neurology Department (blinded for peer review) in the duration from November 2021 to May 2022. The objectives of the research and study procedures were clarified to each applicant and an informed written consent was obtained and assigned from each participant before being involved in the research. The Helsinki Declaration of Biomedical Ethics, as updated, was followed in the study's design. The study received the ethical approval from the Neurology Department (blinded for peer review) in 8/2/2022 with approval number (MS-518-2021). The research involved two groups: group (A) which included 36 IIH patients and group (B) which included 36 healthy matched controls for age and sex.

Inclusion criteria: IIH patients who were admitted at department of Neurology or following up in the headache clinic (blinded for peer review) and diagnosed as IIH following the international classification of headache, ICHD-3, their age ranged from 20 to 45 years of both sex groups with normal brain parenchyma without evidence of hydrocephalus, mass or structural lesion in MRI of the brain which may cause secondary increase in ICP [6].

Exclusion criteria: Cases of venous thrombosis, autoimmune disorders or vasculitis which may cause secondary increase in ICP were excluded. Comorbid medical or ophthalmological conditions which can affect the visual pathway like hypertension, diabetes mellitus or glaucoma, and pregnant females were also excluded from our study.

Study procedures: Patients were evaluated clinically by detailed history taking, general and neurological examination. Body mass index (BMI) was calculated by dividing an adult's weight in kilograms by their height in meters squared and subjects were considered overweight when BMI ranged between 25.0–29.9 kg/m2 and obese with BMI ranged 30 kg/m2 and above according to World Health Organization BMI cutoff points [7]. Headache was evaluated according to the headache sheet of Neurology department (blinded for peer review), which includes all the clinical characteristics of headache about duration, severity, aura, frequency, laterality and daily activities interference. Assessment of headache severity was done using comparative pain rating scale which is a scale of (0–10), where 0 is no pain, minor pain which does not interfere with most activities included (1 = very mild or 2 = discomforting or 3 = tolerable), moderate pain which interferes with many activities included (4 = distressing or 5 = very distressing or 6 = intense), severe pain which is unable to engage in normal activities included (7 = very intense, 8 = horrible, 9 = unbearable) and 10 is the worst unimaginable pain [8]. Relapses of IIH were assessed since the onset of diagnosis and treatment according to Yri and colleagues who defined relapse as recurrence of either previous resolved papilledema or symptoms of elevated ICP as blurred vision or diplopia, transient visual obscurations (TVOs) and pulsatile tinnitus that need crucial management by lumbar puncture (LP) or shunt [9]. Ophthalmological evaluation was done by ophthalmologists in ophthalmology outpatient clinic (blinded for peer review) through visual acuity assessment, fundus examination to detect the degree of papilledema according to Modified Frisen Scale [10]. Visual field assessment was done using the automated perimetry (Humphrey visual field Ziess, Germany) and grading of perimetry was done according to Wall M and George D grading scales [11].

Magnetic resonance imaging (MRI) of the brain was done for all patients to exclude secondary causes of ICP elevation. Magnetic resonance venography (MRV) was done to identify any venous system abnormalities like attenuation, filling defects or thrombosis, in venous sinuses [12]. MRI and MRV were performed at the Diagnostic Radiology Department, (blinded for peer review). Scans were done on a 1.5 Tesla Philips Intera scanner (Brand: Philips, Model: 1.5 Tesla Philips Intera scanner, made in United States), the imaging findings were interpreted by the radiologists.

To quantify the CSF opening pressure, all patients underwent LP with an LP needle under complete aseptic conditions. When performing LP, the patient was lying in the lateral decubitus posture with their legs outstretched for pressure measurements. Reference range for diagnosing IIH: CSF > 200 mm H2O in non-obese subjects and > 250 mm H2O in obese subjects [13].

Laboratory workup included: Complete blood picture with differential count (CBC) to calculate neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), serum IRON, total iron binding capacity (TIBC), serum LDH and C-reactive protein (CRP). Normal levels of LDH in the blood usually range between 140 units per liter (U/L) to 280 U/L for adults [14], also the normal level of CRP which usually seen in most healthy adults is less than (0.3 mg/dL) while ( 0.3 to 1.0 mg/dL): normal or minor elevation (can be seen in obesity, pregnancy, diabetes and common cold,); (1.0 to 10.0 mg/dL): moderate elevation (systemic inflammation or autoimmune diseases,) and more than (10.0 mg/dL): marked elevation (acute bacterial or viral infections, systemic vasculitis) [15].

CBC was performed on an automated hematology analyzer (Sysmex Corporation, Kobe 651–0073, Japan). The NLR and PLR values were calculated by dividing the neutrophil count or the platelet count, respectively, by the lymphocyte count [16].

Sample size calculation: Based on evidence from previous similar study and by considering the neutrophil-to-lymphocyte ratio in patients with papilledema and patients without papilledema as a primary outcome. Epi-Calc 2000 was used to calculate the sample size of this case–control study. Assuming 80% power, 0.05 level of significance using Student’s T-test for independent samples, mean in patients with papilledema = 2.16, mean in patients without papilledema = 1.82, SD = 0.51. The sample size will be = 66 participants (33 in each group). Considering drop-outs rate of 10%, therefore the final sample size will be 72 participants (36 in each group).

Statistical analysis: Statistical analysis was done by using Statistical Package for the Social Sciences (SPSS) 22nd edition, quantitative variables were presented in mean, standard deviation (SD), and range, it was compared using Mann–Whitney U test after applying normality distribution testing. Qualitative variables were presented in count and percentages, it was compared using chi square test (χ2). Spearman correlation test was used to correlate two quantitative variables.

Results

The general features of the study groups are represented in Table 1. No significant difference was found between patients and control groups as regards mean age, gender or contraceptive use (p > 0.05), however, BMI was significantly higher among patients compared to controls (p value = 0.0001 )Table 1

Table 1 General characteristics of participants
Full size table

The disease duration ranged from 1- 10 years with a mean duration of 3.8 ± 2.9 years. Clinical characteristics of headache and ophthalmological assessment are represented in Table 2. Opening CSF pressure ranged from 190–700 mmHg with a mean 326.1 ± 112.8 mmH2O.

Table 2 Clinical, ophthalmological and radiological features of IIH patients
Full size table

MRI of the brain was normal in 18 patients (50%), empty sella was found in five patients (13.9%), and one patient (2.8%) had tortuosity of the optic nerve. MRV showed stenosis in 29 patients (80.6%), 22 of it were in the transverse sinus, four in the transverse, sigmoid sinuses and internal jugular vein and three in the transverse and sigmoid sinuses. MRV abnormalities were unilateral in 12 patients and bilateral in 17 patients. Four patients had (11.1%) inserted shunt Table 2.

Comparison of laboratory markers between study groups showed that LDH, CRP, NLR and PLR were significantly higher and serum iron was significantly lower in IIH patients compared to healthy controls (p value = 0.015, 0.0001, 0.0001, 0.038 and 0.044, respectively)Table 3.

Table 3 Comparison of laboratory markers between study groups
Full size table

Comparison of laboratory parameters in IIH patients with normal and abnormal MRV showed that patients with stenosis in the MRV had significantly higher mean serum CRP compared with patients with normal MRV (p value = 0.044). However, the difference as regards LDH, serum iron, TIBC, NLR or PLR was insignificant (p value > 0.05) Table 4.

Table 4 Comparison of laboratory markers in IIH patients according to MRV findings
Full size table

There was a significant positive correlation between CRP, TIBC, and NLR with BMI (p = 0.0001, 0.049, and 0.023, respectively).

There was a significant positive correlation between serum LDH level and grade of papilledema (p = 0.016). Also, there was a statistically significant positive correlation between TIBC and CSF opening pressure (p = 0.023). There was a significant positive correlation between serum CRP and the presence of stenosis in MRV (p value = 0.047). No significant correlation was found between laboratory parameters with either headache severity, number of relapses or grade of perimetry Table 5

Table 5 Correlation between laboratory parameters and BMI, clinical, ophthalmological, MRV findings and CSF opening pressure in IIH patients
Full size table

Discussion

Few studies in literature had investigated the laboratory profile of patients presented with IIH, denoting that the underlying etiology of IIH may be caused by inflammatory process as the inflammatory markers were higher among IIH patients compered to controls [17].

In this study, BMI was significantly higher in patients group in comparison to controls. This finding was consistent with evidence in literature that proved correlation between high BMI and incidence of IIH [17,18,19]. The pathogenesis of IIH due to obesity has not been yet revealed, however many theories had mentioned aldosterone excess (associated with obesity and polycystic ovary syndrome (PCOS) to be one of the possible mechanisms for IIH among obese females, as the choroid plexus has mineralocorticoid receptor which leads to increased production of CSF [20]. Another theory had been proposed that outflow resistance to CSF might be due to an influence of retinoic acid or estrogen which are elevated by increased adiposity on epithelial cells leading to less CSF outflow [21].

In this study, MRV showed stenosis in 29 patients (80.6%), 22 of them were in the transverse sinus, four in the transverse, sigmoid sinuses and Internal Jugular vein and three in the transverse and sigmoid sinuses. These findings came in consistence with Morris and colleagues, who showed that stenosis of the transverse sinus was detected on MRV in 83% of IIH patients and MRI findings were positive in 60% of included cases [22].

Woodall MN and colleagues discovered that stenosis of the transverse sinuses occurs in 94% of patients with IIH. So, speculation has been raised that venous outflow obstruction may play a role in the genesis of IIH [23], but the reversibility of this finding with effective medical therapy and intracranial pressure reduction suggests that venous occlusive findings are secondary to elevated intracranial pressure rather than vice versa [24].

The current study revealed that LDH, and CRP were significantly higher in IIH patients compared to healthy controls. These findings were in agreement with Pollak and colleagues who reported elevated (CRP) levels in 51% and elevated LDH in 20% of IIH patients [17]. Moreover, the improvement in visual field sensitivity was also poorer for patients with elevated CRP than for those with normal CRP. CRP was also investigated in another study as a marker for inflammation in patients with IIH and concluded that there is increase in CRP in IIH patients in comparison to controls which reflects a low-grade systemic inflammation [25].

C-reactive protein possesses both pro-inflammatory and anti-inflammatory effects. It aids in the identification and removal of invading infections and injured cells, also it can become pathogenic by increasing tissue damage in some situations by activating the complement system and thus inflammatory cytokines. So it is considered as marker of inflammatory process and explained the poorer visual outcome in patients with high CRP [26].

Even among young adults, higher BMI is linked to increased CRP concentrations, according to Qiling Li and colleagues' research [27]. These results point to a low-grade systemic inflammatory state in overweight and obese individuals. In a cross-sectional study that included 7526 males and 3219 females, CRP was also measured, and it was discovered that individuals with abnormal BMI had considerably higher CRP levels than those with normal BMI. This distinction was found to favor females over males [28].. It has recently been determined that obesity causes chronic inflammation, which is linked to the production of inflammatory cytokines from adipose tissue. It is believed that obesity is a pro-inflammatory condition linked to elevated levels of cytokines and adipokines, including macrophage chemotactic protein-1, ghrelin, leptin, and interleukin-6. Although their significance in the etiology of IIH remains unclear, some of them have been observed to be higher in the serum and CSF of individuals with IIH. Therefore, the discovery that half of IIH patients had elevated CRP levels and that this had a detrimental effect on their prognosis could support the theory that inflammation plays a role in the pathogenesis of the illness [29].

Lactic dehydrogenase reflects tissue breakdown and its level is increasing in different disorders like malignancy and hemolysis, so it is believed that elevated LDH among IIH patients reflects hepatic involvement in the form of fatty liver associated with obesity [29].

Neutrophil‑to‑lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are novel hematological parameters for systemic inflammation and stress. NLR and PLR are useful inflammatory markers for many systemic and ocular chronic diseases, and they are associated with the prognosis of various disorders [30].

Dynamic changes of NLR precede the clinical state for several hours and may warn clinicians about the ongoing pathological process early like cancer, atherosclerosis, infection, inflammation, psychiatric disorders and stress [31].

In this study, NLR and PLR were significantly higher in IIH patients in comparison to healthy subjects. This finding was consistent with Ceylan and colleagues, who highlighted that NLR, and PLR were significantly higher in patients with IIH compared to controls. To the best of our knowledge no other studies assessed NLR, and PLR among patients with IIH. Neurologists have thought that using NLR and PLR is a very useful tool in diagnosis and follow-up and looks like a new idea that has added another view on the role of inflammation in IIH [31].

Results of the current study showed that serum iron was significantly lower among IIH group compared to healthy subjects, a finding that was consistent with many studies that correlated anemia with the incidence of IIH. Ma and colleagues showed that IIH patients commonly had iron deficiency anemia (IDA) accounting for 19 out of 22 patients [32].They concluded that chronic blood loss due to menorrhagia is the most common cause of IDA in IIH patients. Moreover, in a large pooled study, the incidence of anemia among IIH cases reached 18.5%, and it was significantly higher compared to controls with relative risk 1.44. The commonest cause of anemia was reported to be iron deficiency accounting for 51.6% [33]. There is a proposed theory that anemia induces hemodynamics alterations that could lead to higher ICP in anemic patients [34]. Reactive thrombocytosis accompanying idiopathic iron deficiency anemia has been suggested as a causative factor, but IIH has also been in patients with anemia and normal thrombocytes as well as the absence of cerebral vein thrombosis. Anemia and tissue hypoxia leading to increased capillary permeability and intracranial pressure has been another proposed theory to explain the relationship between IIH and anemia. In seven out of eight patients with IIH and iron deficiency anemia, IIH resolved on correction of anemia alone [35]

Moreover, some researches have examined the connection between IDA and cerebral venous thrombosis (CVT) with IIH-like presentation [36]..

In the current work, patients with stenosis in the MRV had significantly higher mean serum CRP compared with patients with normal MRV, and there was a statistically significant positive correlation between serum CRP and the presence of stenosis in MRV. Also, IIH patients with MRV results had greater levels of the inflammatory markers CRP and LDH. Inflammatory indicators including CRP and LDH were examined in earlier research among patients with IIH and transverse sinus thrombosis, and it was discovered that individuals with venous sinus thrombosis should be tested for hypercoagulability. Moreover, test abnormalities such as raised C-reactive protein, elevated plasma cortisol, and elevated lactate dehydrogenase have been described, but their clinical relevance is debatable [17].

In the present study, a statistically significant positive correlation between serum LDH level and papilledema grade was found. These results are at odds with those of Pollak and colleagues, who found that patients with increased LDH had better visual outcomes than those with normal LDH [17].

CRP, TIBC, and NLR significantly correlated positively with BMI in our study. These results are largely explained by the fact that obesity leads to a persistent pro-inflammatory state in the body, which may be directly linked to the development of IIH. [37, 38]

The limitations of our study were the limited sample size; we did not study the potential predictive value of inflammatory markers for disease progression and recurrence in IIH patients and the effects of various IIH treatments on inflammatory markers and compare them to clinical outcomes.

Conclusions

According to our study findings, patients with IIH have a considerable rise in inflammatory markers, which may indicate that an inflammatory process is involved in the pathophysiology of IIH. Moreover, cerebral venous sinus stenosis and BMI were positively associated with higher markers of inflammation as CRP, LDH and NLR indicating the role of inflammation in thrombosis and obesity associated with IIH. Hence, inflammatory markers can be used as diagnostic, prognostic and follow-up markers for disease outcomes among patients with IIH.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to the current Cairo University regulations and Egyptian legislation but are available from the corresponding author on reasonable request and after institutional approval.

Abbreviations

BBB:

Blood–brain barrier

BCSFB:

Blood–CSF barrier

BMI:

Body mass index

CNS:

Central nervous system

CVT:

Cerebral venous thrombosis

CSF:

Cerebrospinal fluid

CRP:

C-reactive protein

IIH:

Idiopathic intracranial hypertension

HIS:

International Headache Society

ICP:

Intracranial pressure

IDA:

Iron deficiency anemia

LDH:

Lactic dehydrogenase

LP:

Lumbar puncture

MRI:

Magnetic resonance imaging

MRV:

Magnetic resonance venography

NLR:

Neutrophil-to-lymphocyte ratio

PLR:

Platelet-to-lymphocyte ratio

PCOS:

Polycystic ovary syndrome

TIBC:

Total iron binding capacity

TVO:

Transient visual obscuration

References

  1. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. The idiopathic intracranial hypertension treatment trial. JAMA Neurol. 2014;71(6):693.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021;268(9):3249–68. https://doi.org/10.1007/s00415-020-09943-9.

    Article  PubMed  Google Scholar 

  3. Westgate CS, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6(10):e145346. https://doi.org/10.1172/jci.insight.145346.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372–6. https://doi.org/10.3109/14397595.2015.1091136.

    Article  PubMed  Google Scholar 

  5. Sim PY, Taribagil P, Woollacott IOC, Rashid S, Kidd DP. Idiopathic intracranial hypertension presenting as iron deficiency anemia: a case report. J Med Case Rep. 2021;15(1):45. https://doi.org/10.1186/s13256-020-02631-2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1): 1–211.

  7. Parish DC, Bidot S, Bruce BB, Micieli JA, Blanch RJ, Newman AB, et al. Self-reported weight and height among idiopathic intracranial hypertension patients. J Neuroophthalmol. 2020;40(2):157–62. https://doi.org/10.1097/WNO.0000000000000861.

    Article  PubMed  Google Scholar 

  8. Boonstra AM, Stewart RE, Köke AJ, Oosterwijk RF, Swaan JL, Schreurs KM, et al. Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: variability and influence of sex and catastrophizing. Front Psychol. 2016;30(7):1466. https://doi.org/10.3389/fpsyg.2016.01466.PMID:27746750;PMCID:PMC5043012.

    Article  Google Scholar 

  9. Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol. 2012;259(5):886–94. https://doi.org/10.1007/s00415-011-6273-9.

    Article  PubMed  Google Scholar 

  10. Ahuja S, Anand D, Dutta TK, Roopesh Kumar VR, Kar SS. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography—a case control study. Clin Neurol Neurosurg. 2015;136:95–9. https://doi.org/10.1016/j.clineuro.2015.05.002.

    Article  PubMed  Google Scholar 

  11. Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991;114(1):155–80.

    PubMed  Google Scholar 

  12. Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021;34(1):75–83. https://doi.org/10.1097/WCO.0000000000000885.PMID:33230036;PMCID:PMC7856277.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.

    Article  PubMed  Google Scholar 

  14. Farhana A, Lappin SL. Biochemistry, Lactate Dehydrogenase. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK557536/

  15. Nehring SM, Goyal A, Patel BC. C Reactive Protein. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK441843/.

  16. Nalli C, Somma V, Andreoli L, Büttner T, Schierack P, Mahler M, et al. Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. Auto Immun Highlights. 2018;9(1):6. https://doi.org/10.1007/s13317-018-0106-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pollak L, Zohar E, Glovinsky Y, Huna-Baron R. The laboratory profile in idiopathic intracranial hypertension. Neurol Sci. 2015;36(7):1189–95. https://doi.org/10.1007/s10072-015-2071-y.

    Article  PubMed  Google Scholar 

  18. Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32(2):363–96.

    Article  PubMed  Google Scholar 

  19. Portelli M, Papageorgiou PN. An update on idiopathic intracranial hypertension. Acta neurochir. 2017;159(3):491–9.

    Article  PubMed  Google Scholar 

  20. Salpietro V, Ruggieri M. Pseudotumor cerebri pathophysiology: the likely role of aldosterone. Headache. 2014;7(54):1229–1229.

    Article  Google Scholar 

  21. McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache. 2014;54(3):445–58.

    Article  PubMed  Google Scholar 

  22. Morris PP, Black DF, Port J, Campeau N. Transverse sinus stenosis is the most sensitive MR imaging correlate of idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2017;38(3):471–7. https://doi.org/10.3174/ajnr.A5055.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Woodall MN, Nguyen KD, Alleyne CH Jr, et al. Bilateral transverse sinus stenosis causing intracranial hypertension. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2013-010513.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fraser JA, Leung AE. Reversibility of MRI features of pseudotumor cerebri syndrome. Can J Neurol Sci. 2014;41:530–2.

    Article  CAS  PubMed  Google Scholar 

  25. Hannerz J, Antovic JP, Blombäck M, Edman G, Khademi M, Piehl F. Inflammatory and haemostatic markers in idiopathic intracranial hypertension. J Intern Med. 2011;270(5):496–9. https://doi.org/10.1111/j.1365-2796.2011.02446.x.

    Article  CAS  PubMed  Google Scholar 

  26. Kramer NE, Cosgrove VE, Dunlap K, Subramaniapillai M, McIntyre RS, Suppes TA. clinical model for identifying an inflammatory phenotype in mood disorders. J Psychiatr Res. 2019;113:148–58.

    Article  PubMed  Google Scholar 

  27. Qiling Li, Wang Qi Xu, Wei MY, Qing W, Danita E, et al. C-reactive protein causes adult-onset obesity through chronic inflammatory mechanism. Front Cell Dev Biol. 2020. https://doi.org/10.3389/fcell.2020.00018.

    Article  Google Scholar 

  28. Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort. J Inflamm Res. 2021;25(14):567–73. https://doi.org/10.2147/JIR.S294368.

    Article  Google Scholar 

  29. Sinclair JA, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ, et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunology. 2008;201–202:212–20.

    Article  Google Scholar 

  30. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–88.

    CAS  PubMed  Google Scholar 

  31. Ceylan OM, Yılmaz M, Yilmaz H, Çelikay O, Köylü MT, Turan A. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammation markers in patients with papilledema due to idiopathic intracranial hypertension. Indian J Ophthalmol. 2021;69(6):1499–505. https://doi.org/10.4103/ijo.IJO_2030_20.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ma Z, Jiang H, Meng C, Cui S, Peng J, Wang J. Idiopathic intracranial hypertension in patients with anemia: a retrospective observational study. PLoS ONE. 2020;15(7):e0236828.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yu CW, Waisberg E, Kwok JM, Micieli JA. Anemia and idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neuroophthalmol. 2022;42(1):e78–86. https://doi.org/10.1097/WNO.0000000000001408.

    Article  PubMed  Google Scholar 

  34. Havangi Prakash S, Basavaraju D, Gowda SN. Papilledema and anemia: a rare association. Cureus. 2022;14(6): e25929. https://doi.org/10.7759/cureus.25929.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Mollan SP, Ball AK, Sinclair AJ, Madill SA, Clarke CE, Jacks AS, et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol. 2009;62:105–8.

    Article  CAS  PubMed  Google Scholar 

  36. Kamel WA, Al-Hashel JY, Alexander KJ, Massoud F, Shawaf FA, Huwaidi IEA. Cerebral venous thrombosis in a patient with iron deficiency anemia and thrombocytopenia: a case report. Open Access Maced J Med Sci. 2017;5(7):967–9. https://doi.org/10.3889/oamjms.2017.216.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75. https://doi.org/10.3945/an.115.010207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Apostolopoulos V, de Courten MP, Stojanovska L, Blatch GL, Tangalakis K, de Courten B. The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res. 2016;60(1):43–57. https://doi.org/10.1002/mnfr.201500272.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge subjects for their participation and cooperation in this study.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Ebtesam Mohamed Fahmy, Reham Mohamed Shamlol, Doaa Youssry, Asmaa Ali Elfiky & Haidy Elshebawy

  2. Clinical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Sahar Abdelatty Sharaf

Authors
  1. Ebtesam Mohamed Fahmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sahar Abdelatty Sharaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reham Mohamed Shamlol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doaa Youssry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Asmaa Ali Elfiky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haidy Elshebawy
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EMF: research idea, data acquisition, data analysis and interpretation, SAS: collection of samples from the studied groups, RMS: data acquisition, data analysis and interpretation, DY: manuscript writing and reviewing , AAE: research idea and manuscript writing , HE: data acquisition, data interpretation and manuscript writing and reviewing . All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Haidy Elshebawy.

Ethics declarations

Ethics approval and consent to participate

An informed written consent was taken from each patient. All data obtained from every patient were confidential and were not used outside the study. The patients have rights to withdraw from the study at any time without giving any reason. All the cost of the investigations was afforded by the researcher. The study design followed the requirements of revised Helsinki declaration of biomedical ethics. Our study was approved by ethical committee of the Department of Neurology, Faculty of Medicine, Cairo University on 8/2/2022 ( approval code MS-518-2021).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fahmy, E.M., Sharaf, S.A., Shamlol, R.M. et al. Association between laboratory markers, clinical and radiological findings in patients with idiopathic intracranial hypertension: case–control study. Egypt J Neurol Psychiatry Neurosurg 60, 115 (2024). https://doi.org/10.1186/s41983-024-00894-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-024-00894-w

Keywords